These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

987 related items for PubMed ID: 17151338

  • 1. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ, Welle S, Venance SL, Thornton CA, Tawil R.
    Neurology; 2007 Feb 20; 68(8):569-77. PubMed ID: 17151338
    [Abstract] [Full Text] [Related]

  • 2. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, van der Maarel SM, Hayashi Y, Flanigan KM.
    Hum Mol Genet; 2003 Nov 15; 12(22):2895-907. PubMed ID: 14519683
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S, Ehrlich M.
    Hum Mol Genet; 2003 Nov 15; 12(22):2909-21. PubMed ID: 14506132
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L, Eagle M, Haggerty ID, Roberts CE, Straub V, Bushby KM.
    Neuromuscul Disord; 2006 Oct 15; 16(9-10):553-8. PubMed ID: 16934468
    [Abstract] [Full Text] [Related]

  • 7. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M, Cooper DN.
    Expert Rev Mol Diagn; 2002 Mar 15; 2(2):160-71. PubMed ID: 11962336
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
    Tsien F, Sun B, Hopkins NE, Vedanarayanan V, Figlewicz D, Winokur S, Ehrlich M.
    Mol Genet Metab; 2001 Nov 15; 74(3):322-31. PubMed ID: 11708861
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSHD).
    Wood-Allum C, Brennan P, Hewitt M, Lowe J, Tyfield L, Wills A.
    Neuropathol Appl Neurobiol; 2004 Apr 15; 30(2):188-91. PubMed ID: 15043716
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
    Butz M, Koch MC, Müller-Felber W, Lemmers RJ, van der Maarel SM, Schreiber H.
    J Neurol; 2003 Aug 15; 250(8):932-7. PubMed ID: 12928911
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Facioscapulohumeral dystrophy.
    Kissel JT.
    Semin Neurol; 1999 Aug 15; 19(1):35-43. PubMed ID: 10711987
    [Abstract] [Full Text] [Related]

  • 20. Facioscapulohumeral muscular dystrophy.
    Tawil R.
    Curr Neurol Neurosci Rep; 2004 Jan 15; 4(1):51-4. PubMed ID: 14683629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.